Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is assess the safety and tolerability of long-term
epratuzumab treatment in subjects with Systemic Lupus Erythematosus (SLE)